Immunic Inc (10VA.BE)
Berlin - Berlin Delayed price. Currency in EUR
Add to watchlist
As of 08:10AM CEST. Market open.
| Previous close | 0.9915 |
| Open | 0.9005 |
| Bid | 0.8920 x N/A |
| Ask | 0.9520 x N/A |
| Day's range | 0.9005 - 0.9005 |
| 52-week range | 0.8905 - 2.5860 |
| Volume | |
| Avg. volume | 0 |
| Market cap | N/A |
| Beta (5Y monthly) | N/A |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | 01 Aug 2024 - 05 Aug 2024 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
Simply Wall St.When Will Immunic, Inc. (NASDAQ:IMUX) Breakeven?
With the business potentially at an important milestone, we thought we'd take a closer look at Immunic, Inc.'s...
PR NewswireImmunic to Participate in Industry and Scientific Conferences in June
Immunic, Inc. (Nasdaq: IMUX), a biotechnology company developing a clinical pipeline of orally administered, small molecule therapies for chronic inflammatory and autoimmune diseases, today announced participation in the following industry and scientific conferences in June:
Insider MonkeyImmunic, Inc. (NASDAQ:IMUX) Q1 2024 Earnings Call Transcript
Immunic, Inc. (NASDAQ:IMUX) Q1 2024 Earnings Call Transcript May 8, 2024 Immunic, Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Jessica Breu: Good morning, and welcome to Immunic First Quarter 2024 Earnings Call. My name is Jessica Breu, Vice President, […]
© 2024 Yahoo. All rights reserved.